EXHIBIT 11
CYTOCLONAL PHARMACEUTICS INC.
COMPUTATION OF NET (LOSS) PER COMMON SHARE
(unaudited)
THREE MONTHS NINE MONTHS
ENDED SEPTEMBER 30, ENDED SEPTEMBER 30,
1999 1998 1999 1998
------------ ------------ ------------ ------------
Net (loss) ($ 1,012,000) ($ 976,000) ($ 2,924,000) ($ 1,935,000)
Add cumulative preferred dividend (46,000) (48,000) (137,000) (143,000)
------------ ------------ ------------ ------------
NET (LOSS) USED FOR COMPUTATION ($ 1,058,000) ($ 1,024,000) ($ 3,061,000) ($ 2,078,000)
Weighted average number of common
shares outstanding - basic and
diluted 10,361,000 10,172,000 10,318,000 9,585,000
------------ ------------ ------------ ------------
Net (loss) per common share -
basic and diluted ($ 0.10) ($ 0.10) ($ 0.30) ($ 0.22)